We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$3.22B
AUM Growth
-$72.5M
Cap. Flow
-$765M
Cap. Flow %
-23.77%
Top 10 Hldgs %
76.64%
Holding
93
New
9
Increased
14
Reduced
27
Closed
16

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$41.4M
2
IBB icon
iShares Biotechnology ETF
IBB
+$28.7M
3
TWX
Time Warner Inc
TWX
+$15.6M
4
BFH icon
Bread Financial
BFH
+$10.6M
5
CALM icon
Cal-Maine
CALM
+$10.2M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$17.7M
2
MRVL icon
Marvell Technology
MRVL
+$11M
3
TSLA icon
Tesla
TSLA
+$9.56M
4
IMAX icon
IMAX
IMAX
+$7.62M
5
JOYY
JOYY Inc
JOYY
+$7.52M

Sector Composition

Rank Sector Weight
1 Healthcare 55.59%
2 Consumer Discretionary 3.25%
3 Communication Services 2.67%
4 Financials 2.32%
5 Energy 1.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
51
Regenxbio
RGNX
$623M
$3.73M 0.12%
193,432
-56,672
-23% -$1.09M
BLCM
52
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3.71M 0.12%
30,072
-3,720
-11% -$487K
KRE icon
53
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$3.36M 0.1%
61,491
-55,269
-47% -$3.09M
CASC
54
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.31M 0.1%
+800,000
New +$3.36M
BIIB icon
55
Biogen
BIIB
$29.9B
$3.21M 0.1%
11,760
– –
PFF icon
56
iShares Preferred and Income Securities ETF
PFF
$13.2B
$1.98M 0.06%
+51,194
New +$1.96M
AKTX
57
Akari Therapeutics
AKTX
$15.2M
$1.89M 0.06%
261
-62
-19% -$347K
HYG icon
58
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$1.58M 0.05%
+18,014
New +$1.57M
TCON
59
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1.27M 0.04%
1,698
-209
-11% -$187K
PTN
60
Palatin Technologies
PTN
$13.7M
$985K 0.03%
3,437
-1,655
-33% -$824K
INSW icon
61
International Seaways
INSW
$4.57B
$350K 0.01%
18,309
– –
BIVV
62
DELISTED
Bioverativ Inc. Common Stock
BIVV
$320K 0.01%
+5,879
New +$290K
GLF
63
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$213K 0.01%
+607,500
New +$699K
ATHM icon
64
Autohome
ATHM
$2.43B
– –
-201,900
Closed -$5.1M
BLK icon
65
PUT
Blackrock
BLK
$164B
– –
-40,000
Closed -$15.2M
IBB icon
66
CALL
iShares Biotechnology ETF
IBB
$9.31B
– –
-300,000
Closed -$26.5M
IMAX icon
67
IMAX
IMAX
$2.38B
– –
-242,741
Closed -$7.62M
MRVL icon
68
Marvell Technology
MRVL
$174B
– –
-789,576
Closed -$11M
NAT icon
69
Nordic American Tanker
NAT
$1.37B
– –
-286,511
Closed -$2.37M
TSLA icon
70
Tesla
TSLA
$1.24T
– –
-671,190
Closed -$9.56M
TSLA icon
71
PUT
Tesla
TSLA
$1.24T
– –
-669,900
Closed -$1.05M
TSM icon
72
PUT
TSMC
TSM
$2.09T
– –
-400,000
Closed -$11.5M
JOYY
73
JOYY Inc
JOYY
$3.73B
– –
-190,700
Closed -$7.52M
SRLP
74
DELISTED
SPRAGUE RESOURCES LP
SRLP
– –
-30,909
Closed -$785K
HMLP
75
DELISTED
HOEGH LNG PARTNERS LP
HMLP
– –
-175,000
Closed -$3.33M
1 2
3
4

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q1 2017 Portfolio in Review

As of Q1 2017, QVT Financial held 93 positions worth $3.22B, down 2.2% from $3.29B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

QVT Financial withdrew a net $765M in Q1 2017, closing 16 positions and reducing 27 holdings. Its most notable exit was Marvell Technology, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 49% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in Allergan plc worth $42.4M.

  • QVT Financial's largest Q1 2017 buy was Allergan plc: 50,000 shares worth $42.4M.
  • QVT Financial added most to iShares Biotechnology ETF in Q1 2017, an estimated $28.7M increase.
  • QVT Financial's biggest Q1 2017 reduction was Intel, cutting an estimated $17.7M.
  • QVT Financial fully exited Marvell Technology in Q1 2017, selling an estimated $11M.
  • QVT Financial's ten largest holdings make up 77% of its $3.22B portfolio in Q1 2017.
  • QVT Financial opened 9 new positions and closed 16 in Q1 2017.
  • QVT Financial's portfolio value fell 2.2% quarter-over-quarter to $3.22B.

Based on QVT Financial's 13F filing for Q1 2017, filed 15 May 2017.